Bird flu, Avian influenza, Diabetes, Cholesterol, Caner, HIV

Medical News Today - Diabetes (6 unread)

Biodel To Report Results Of VIAject™ Pivotal Phase III Clinical Trials At EASD Conference

Posted: September 5th, 2008, 6:00am EDT

Biodel Inc. (Nasdaq: BIOD) announced that it will report results of its two pivotal Phase III clinical trials of VIAject™ in patients with Type 1 and Type 2 diabetes next week at the 44th Annual Meeting of the European Association for the Study of Diabetes in Rome. Two posters summarizing these results, #677 by Flacke et al.
Physicians Eager To Increase Their First- And Second-Line Prescriptions For Januvia Over The Next Two Years For The Treatment Of Type 2 Diabetes

Posted: September 5th, 2008, 6:00am EDT

Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that Merck's Januvia is currently prescribed most often as a third- or later-line of therapy for the treatment of type 2 diabetes.
OSI Pharmaceuticals Initiates Clinical Development Program For Anti-Diabetes Candidate, PSN821

Posted: September 5th, 2008, 6:00am EDT

OSI Pharmaceuticals, Inc. (Nasdaq: OSIP) announced that it has initiated a first-in-human clinical study for its G-protein coupled receptor GPR119 agonist, PSN821, which the Company is developing for the treatment of type 2 diabetes. Discovered by OSI's diabetes and obesity research team, PSN821 demonstrated both effective glucose lowering and substantial reductions of body weight in pre-clinical studies.
Blood 'Fingerprints' For Cancer

Posted: September 5th, 2008, 5:00am EDT

Serum microRNAs (miRNAs) can serve as biomarkers for the detection of diseases including cancer and diabetes, according to research published online this week in Cell Research. The findings pave the way for a revolutionary non-invasive diagnostic tool. miRNAs are a class of naturally occurring small non-coding RNAs that have been linked with cancer development.
Mechanism Of Cell Death Clarified In Oxidative Stress

Posted: September 5th, 2008, 4:00am EDT

Dr. Marcus Conrad of the Institute of Clinical Molecular Biology and Tumor Genetics at the Helmholtz Zentrum MÃ¼nchen has decrypted the molecular mechanism through which the death of cells is caused by oxidative stress. This knowledge opens novel perspectives to systematically explore the benefit of targeted therapeutic interventions in the cure of ageing and stress-related degenerative diseases.
Immune Responses In Disease Monitored

Posted: September 5th, 2008, 3:00am EDT

A recent study (doi:10.1016/j.clim.2008.06.009) published in Clinical Immunology, the official journal of the Clinical Immunology Society (CIS), describes a new method enabling the detection of multiple parameters of single human cells. The report demonstrates the characterization of specific blood cells from an individual with type 1 diabetes, providing information about the role these cells might play in the development of the disease and during therapy.

← September 4 (2 items) September 6 (3 items) →

My Health News » Medical News Today - Diabetes » September 5, 2008

Feeds

Medical News Today - Diabetes (6 unread)

Biodel To Report Results Of VIAject™ Pivotal Phase III Clinical Trials At EASD Conference

Posted: September 5th, 2008, 6:00am EDT

Physicians Eager To Increase Their First- And Second-Line Prescriptions For Januvia Over The Next Two Years For The Treatment Of Type 2 Diabetes

Posted: September 5th, 2008, 6:00am EDT

OSI Pharmaceuticals Initiates Clinical Development Program For Anti-Diabetes Candidate, PSN821

Posted: September 5th, 2008, 6:00am EDT

Blood 'Fingerprints' For Cancer

Posted: September 5th, 2008, 5:00am EDT

Mechanism Of Cell Death Clarified In Oxidative Stress

Posted: September 5th, 2008, 4:00am EDT

Immune Responses In Disease Monitored

Posted: September 5th, 2008, 3:00am EDT